Publications

• Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.
  Transplantation Volume: 105 Page(s): e395 - e396
  12/01/2021 Authors: Badell IR; Bray RA; Elbein R; Chami AS; Easley KA; Pastan SO; Guasch A; Gebel HM; Adams AB; Larsen CP
• Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up.
  Am J Transplant Volume: 20 Page(s): 3609 - 3619
  12/01/2020 Authors: Schmitz R; Fitch ZW; Xu H; Ghali A; Mehta AK; Guasch A; Kirk AD
• B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.
  Am J Transplant Volume: 20 Page(s): 653 - 662
  03/01/2020 Authors: Xu H; Mehta AK; Gao Q; Lee H-J; Ghali A; Guasch A; Kirk AD
• Four-Year Follow Up of Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy.
  Volume: 19 Page(s): 450 - 450
  04/01/2019 Authors: Kirk A; Xu H; Ghali A; Mehta A; Guasch A
• B Cell Reconstitution: 36-Month Analysis of Patients Post-Alemtuzumab Induction Followed by Belatacept-Based Immunosuppression.
  Volume: 18 Page(s): 448 - 448
  06/01/2018 Authors: Gao Q; Mehta A; Guasch A; Ghali A; Kirk A; Xu H
• Long-Term Outcomes of a Steroid-Free, Belatacept-Based Immunosuppressive Regimen Plus Sirolimus Using Alentuzumab Induction in Renal Transplantation.
  Volume: 18 Page(s): 805 - 805
  06/01/2018 Authors: Guasch A; Ghali A; Mead S; Mehta A; Xu H; Kirk A
• Emergence of a Costimulation-Susceptible T Cell Repertoire Post-Alemtuzumab Induction.
  Volume: 18 Page(s): 449 - 449
  06/01/2018 Authors: Gao Q; Mehta A; Guasch A; Stempora L; Kirk A; Xu H
• Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia.
  Blood Cells Mol Dis Volume: 69 Page(s): 65 - 70
  03/01/2018 Authors: Yee ME; Lane PA; Archer DR; Joiner CH; Eckman JR; Guasch A
• Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
  Am J Transplant Volume: 17 Page(s): 2922 - 2936
  11/01/2017 Authors: Adams AB; Goldstein J; Garrett C; Zhang R; Patzer RE; Newell KA; Turgeon NA; Chami AS; Guasch A; Kirk AD
• Estimation of glomerular filtration rate using serum cystatin C and creatinine in adults with sickle cell anemia.
  Am J Hematol Volume: 92 Page(s): E598 - E599
  10/01/2017 Authors: Yee MEM; Lane PA; Archer DR; Joiner CH; Eckman JR; Guasch A
• Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR (R) Gel.
  Volume: 16 Page(s): 344 - 344
  06/01/2016 Authors: Vaitla P; Daswatta D; Guasch A
• A Pathway to Belatacept Monotherapy: Alemtuzumab, Belatacept and Rapamycin for Kidney Transplantation.
  Volume: 16 Page(s): 303 - 303
  06/01/2016 Authors: Guasch A; Xu H; Mehta A; Ghali A; Mead S; Gebel H; Bray R; Larsen C; Pearson T; Kirk A
• Post-Trial Experience with Belatacept: A Large Single Center Experience.
  Volume: 16 Page(s): 741 - 741
  06/01/2016 Authors: Adams A; Garrett C; Goldstein J; Zhang R; Guasch A; Pastan S; Patzer R; Kirk A; Pearson T; Larsen C
• COMPLEMENT FACTOR H GENE MUTATION REPRODUCING THE SPRECTRUM FROM ATYPICAL HEMOLYTIC UREMIC SYNDROME TO C3 GLOMERULOPATHY
  Volume: 67 Page(s): A91 - A91
  05/01/2016 Authors: Saad M; Ellis C; Guasch A
• Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
  Am J Transplant Volume: 16 Page(s): 550 - 564
  02/01/2016 Authors: Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
• Estimation of Glomerular Filtration Rate (GFR) Using Serum Cystatin C and Creatinine Has Poor Precision and Accuracy in Adults with HbSS Sickle Cell Disease
  Volume: 126
  12/03/2015 Authors: Yee ME; Lane PA; Eckman JR; Guasch A
• Angiotensin Blockage with Losartan Is Associated with Decreased Albuminuria and Stable Renal Function in Adults and Children with HbSS on Hydroxyurea
  Volume: 126
  12/03/2015 Authors: Yee ME; Lane PA; Eckman JR; Guasch A
• Induction of a Costimulation-Susceptible Repertoire: A Case for Depletional Prior to Belatacept
  Volume: 15
  05/01/2015 Authors: Xu H; Samy K; Guasch A; Mead S; Kirk A
• Deceased Donor Kidney Transplantation Without Calcineurin Inhibitors or Steroids
  Volume: 15
  05/01/2015 Authors: Kirk A; Guasch A; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Larsen C; Pearson T
• Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
  Volume: 98 Page(s): 80 - 80
  07/15/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J
• Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
  Volume: 14 Page(s): 80 - 80
  06/01/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J
• Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
  Am J Transplant Volume: 14 Page(s): 1142 - 1151
  05/01/2014 Authors: Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R
• Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
  N Engl J Med Volume: 369 Page(s): 2492 - 2503
  12/26/2013 Authors: de Zeeuw D; Akizawa T; Audhya P; Bakris GL; Chin M; Christ-Schmidt H; Goldsberry A; Houser M; Krauth M; Lambers Heerspink HJ
• Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.
  Blood Volume: 122 Page(s): 434 - 442
  07/18/2013 Authors: Galarneau G; Coady S; Garrett ME; Jeffries N; Puggal M; Paltoo D; Soldano K; Guasch A; Ashley-Koch AE; Telen MJ
• Atypical presentation of perforated sigmoid diverticulitis in a kidney transplant recipient with autosomal dominant polycystic kidney disease.
  Hawaii J Med Public Health Volume: 72 Page(s): 216 - 218
  07/01/2013 Authors: Tantisattamo E; Guasch A
• THE FABRAZYME (R), ANGIOTENSIN RECEPTOR BLOCKER AND ACE INHIBITOR TREATMENT STUDY FOR FABRY NEPHROPATHY (FOR THE FAACET INVESTIGATORS)
  Volume: 28 Page(s): 321 - 321
  05/01/2013 Authors: Warnock D; Guasch A; Thomas C; Wanner C; Campbell R; Vujkovac B
• MEDICAL TRAVELER-A LESSON TO BE LEARNED?
  Volume: 61 Page(s): A72 - A72
  04/01/2013 Authors: Oommen A; Guasch A
• High one year mortality in adults with sickle cell disease and end-stage renal disease.
  Br J Haematol Volume: 159 Page(s): 360 - 367
  11/01/2012 Authors: McClellan AC; Luthi J-C; Lynch JR; Soucie JM; Kulkarni R; Guasch A; Huff ED; Gilbertson D; McClellan WM; DeBaun MR
• Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy
  Volume: 12 Page(s): 197 - 197
  05/01/2012 Authors: Kirk AD; Mehta AK; Guasch A; Mead S; Xu H; Cheeseman J; Horan J; Kean L; Larsen CP; Pearson TC
• PERSPECTIVES OF TRANSPLANTATION AS SHARED BY AFRICAN AMERICAN DIALYSIS PATIENTS
  Volume: 43 Page(s): S134 - S134
  04/01/2012 Authors: Perryman JP; Robinson DH; Arriola KRJ; Cowen KU; Guasch A; Pearson TC; Thompson NJ
• Chronic kidney disease and albuminuria in children with sickle cell disease.
  Clin J Am Soc Nephrol Volume: 6 Page(s): 2628 - 2633
  11/01/2011 Authors: McPherson Yee M; Jabbar SF; Osunkwo I; Clement L; Lane PA; Eckman JR; Guasch A
• Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy.
  Volume: 11 Page(s): 45 - 45
  04/01/2011 Authors: Kirk AD; Mead S; Xu H; Mehta A; Guasch A; Cheeseman J; Joseph J; Horan J; Kean L; Larsen CP
• Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
  Transplantation Volume: 90 Page(s): 891 - 897
  10/27/2010 Authors: Guasch A; Roy-Chaudhury P; Woodle ES; Fitzsimmons W; Holman J; First MR; FK778 BK Nephropathy Study Group
• Improving renal outcomes in chronic anemia: learning from paroxysmal nocturnal hemoglobinuria.
  Am J Hematol Volume: 85 Page(s): 551 - 552
  08/01/2010 Authors: Guasch A
• Impact of immunosuppression reduction in BK viremic patients: 3 year follow-up
  Volume: 8 Page(s): 284 - 284
  05/01/2008 Authors: Kuppachi S; Guasch A; Larsen CP; Kokko KE
• BK nephropathy in HIV positive renal transplant recipients.
  Volume: 8 Page(s): 460 - 460
  05/01/2008 Authors: Blumberg E; Barin B; Bloom R; Roland M; Olson J; Wali R; Guasch A; Zhang R; Pavlakis M; Stock P
• Accuracy of eGFR equations to detect changes in renal function in renal transplant recipients.
  Volume: 8 Page(s): 452 - 452
  05/01/2008 Authors: El-Minshawy O; Guasch A
• Performance of current equations for estimation of GFR in different stages of CKD among renal transplant recipients
  Volume: 51 Page(s): A70 - A70
  04/01/2008 Authors: El Minshawy O; Guasch A
• Conversion to sirolimus from a calcineurin inhibitor based protocol does not worsen proteinuria or glomerular permeability to macromolecules in patients with chronic allograft nephropathy.
  Volume: 7 Page(s): 441 - 441
  05/01/2007 Authors: Guasch A; Barakat I; Near M; Selvaraj S
• Transplanting the highly sensitized patient: The emory algorithm.
  Am J Transplant Volume: 6 Page(s): 2307 - 2315
  10/01/2006 Authors: Bray RA; Nolen JDL; Larsen C; Pearson T; Newell KA; Kokko K; Guasch A; Tso P; Mendel JB; Gebel HM
• Albuminuria and kidney disease in patients with sickle cell anemia
  ETHNICITY & DISEASE Volume: 16 Page(s): 15 - 16
  09/01/2006 Authors: Moore D; Guasch A
• Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
  J Am Soc Nephrol Volume: 17 Page(s): 2228 - 2235
  08/01/2006 Authors: Guasch A; Navarrete J; Nass K; Zayas CF
• Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).
  Clin Nephrol Volume: 66 Page(s): 103 - 111
  08/01/2006 Authors: Budde K; Knoll G; Curtis J; Chan L; Pohanka E; Gentil M; Seifu Y; Marrast AC; Neumayer HH; ERL B302 Study Group
• A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
  Clin J Am Soc Nephrol Volume: 1 Page(s): 109 - 116
  01/01/2006 Authors: Tumlin JA; Miller D; Near M; Selvaraj S; Hennigar R; Guasch A
• Comparable graft survival in sensitized and unsensitized renal transplant recipients: A 5 year single center review.
  Volume: 5 Page(s): 456 - 456
  05/01/2005 Authors: Nolen JDL; Gebel HM; Larsen C; Pearson T; Newell K; Kokko K; Guasch A; Tso P; Bray RA
• A 5 year single center review of graft survival in sensitized renal transplant recipients
  Volume: 66 Page(s): S56 - S56
  01/01/2005 Authors: Nolen JDL; Bray RA; Pearson T; Larsen C; Newell K; Kokko K; Guasch A; Tso P; Gebel HM
• The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.
  Volume: 66 Page(s): 1145 - 1152
  09/01/2004 Authors: Szczech LA; Gupta SK; Habash R; Guasch A; Kalayjian R; Appel R; Fields TA; Svetkey LP; Flanagan KH; Klotman PE
• Determinants of long-term preservation of renal functional after conversion to sirolimus in patients with chronic allograft nephropathy.
  Volume: 4 Page(s): 266 - 266
  01/01/2004 Authors: Guasch A; Near M; Selvaraj S
• Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients.
  Am J Transplant Volume: 3 Page(s): 1581 - 1586
  12/01/2003 Authors: Pescovitz MD; Guasch A; Gaston R; Rajagopalan P; Tomlanovich S; Weinstein S; Bumgardner GL; Melton L; Ducray PS; Banken L
• Transgenic sickle cell mice develop a glomerular lesion similar to human sickle cell glomerulopathy.
  Volume: 102 Page(s): 30B - 30B
  11/16/2003 Authors: Guasch A; Waqas M; Niaz S; Hsu LL
• Efficacy of rapamycin in steroid-resistant, FK-506-Dependent FSGS: Stabilization of renal function and reduction in proteinuria.
  Volume: 14 Page(s): 524A - 524A
  11/01/2003 Authors: Tumlin JA; Miller DR; Guasch A
• Increased expression of glomerular endothelial, adhesion molecules in patients with sickle cell glomerulopathy.
  Volume: 14 Page(s): 759A - 759A
  11/01/2003 Authors: Guasch A; Niaz S; Selvaraj S; Wang SS
• Transmission of West Nile virus from an organ donor to four transplant recipients.
  N Engl J Med Volume: 348 Page(s): 2196 - 2203
  05/29/2003 Authors: Iwamoto M; Jernigan DB; Guasch A; Trepka MJ; Blackmore CG; Hellinger WC; Pham SM; Zaki S; Lanciotti RS; Lance-Parker SE
• Clinical features of West Nile virus infection in solid organ transplant recipients
  Volume: 41 Page(s): A32 - A32
  04/01/2003 Authors: Salameh M; DiazGranados C; Guasch A
• Fatal West Nile virus infection in renal transplant recipient
  Volume: 16 Page(s): 5A - 5A
  01/01/2003 Authors: Cushing MM; Brat DJ; Mosunjac MI; Guasch A; Hennigar RA; Jernigan D; Petersen L; Goldsmith C; Shieh WJ; Guarner I
• Fatal west nile virus infection in renal transplant recipient
  Volume: 83 Page(s): 5A - 5A
  01/01/2003 Authors: Cashing MM; Brat DJ; Mosunjac MI; Guasch A; Hennigar RA; Jemigan D; Petersen L; Goldsmith C; Shieh WJ; Guarner J
• Lack of association between the insertion/deletion (I/D) polymorphisms of the angiotensin converting enzyme gene (ACE) and early sickle cell glomerulopathy.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 13 Page(s): 132A - 132A
  09/01/2002 Authors: Rebala S; Muralidharan K; Eckman JR; Elsas LJ; Guasch A
• Effects of angiotensin blockade with losartan on glomerular function in patients with sickle cell glomerulopathy.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 13 Page(s): 265A - 266A
  09/01/2002 Authors: Rebala S; Guasch A
• Mechanisms of improvement in renal function after conversion to sirolimus (SRL) from a calcineurin-inhibitor (CI) regimen in patients with chronic transplant nephropathy (CTN).
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 13 Page(s): 365A - 365A
  09/01/2002 Authors: Barakat IB; Zayas CF; Guasch A
• Early glomerular dysfunction in human renal allografts.
  Kidney Int Volume: 60 Page(s): 1938 - 1947
  11/01/2001 Authors: Zayas CF; Guasch A
• Sickle cell patients have elevated erythropoietin levels despite low glomerular filtration rate.
  BLOOD Volume: 96 Page(s): 14A - 14A
  11/16/2000 Authors: Neel J; Tamim H; Guasch A; Kasey S; Eckman JR
• F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.
  Kidney Int Volume: 58 Page(s): 1963 - 1972
  11/01/2000 Authors: Montero A; Munger KA; Khan RZ; Valdivielso JM; Morrow JD; Guasch A; Ziyadeh FN; Badr KF
• MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
  Kidney Int Volume: 56 Page(s): 261 - 267
  07/01/1999 Authors: Guasch A; Zayas CF; Badr KF
• Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans.
  J Am Soc Nephrol Volume: 10 Page(s): 1014 - 1019
  05/01/1999 Authors: Guasch A; Zayas CF; Eckman JR; Muralidharan K; Zhang W; Elsas LJ
• Albuminuria is a marker of progressive renal insufficiency in human renal allografts.
  TRANSPLANTATION Volume: 67 Page(s): S27 - S27
  04/15/1999 Authors: Guasch A; Powars B; Zayas CF; Neylan JF
• Mechanisms of the antiproteinuric effect of MK-591, a leukotriene biosynthesis inhibitor, in human glomerulonephritis.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 8 Page(s): A0412 - A0412
  09/01/1997 Authors: Guasch A; Zayas CF; Badr KF
• A morphometric analysis of chronic rejection.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 8 Page(s): A3290 - A3290
  09/01/1997 Authors: Zayas CF; Guasch A
• Glomerular dysfunction in well functioning renal allografts.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 8 Page(s): A3182 - A3182
  09/01/1997 Authors: Guasch A; Zayas CF; Neylan J
• Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
  J Am Soc Nephrol Volume: 8 Page(s): 793 - 798
  05/01/1997 Authors: Guasch A; Parham M; Zayas CF; Campbell O; Nzerue C; Macon E
• Sickle cell anemia causes a distinct pattern of glomerular dysfunction.
  Kidney Int Volume: 51 Page(s): 826 - 833
  03/01/1997 Authors: Guasch A; Cua M; You W; Mitch WE
• Therapeutic effect of leukotriene biosynthesis inhibition in proliferative glomerulonephritis: Results of the first human trial.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 7 Page(s): A0441 - A0441
  09/01/1996 Authors: Guasch A; Zayas CF; Badr KF
• Prevalence and predictors of glomerular involvement in sickle cell anemia
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 7 Page(s): A0780 - A0780
  09/01/1996 Authors: Zayas CF; Platt A; Eckman J; Elsas L; Clark WS; Mitch WE; Guasch A
• Sickle cell anemia causes a distinct pattern of glomerular dysfunction.
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 7 Page(s): A0440 - A0440
  09/01/1996 Authors: Guasch A; Cua M; You W; Mitch WE
• Early detection and the course of glomerular injury in patients with sickle cell anemia.
  Kidney Int Volume: 49 Page(s): 786 - 791
  03/01/1996 Authors: Guasch A; Cua M; Mitch WE
• EVIDENCE FOR GLOMERULAR CAPILLARY WALL INJURY IN SICKLE-CELL GLOMERULOPATHY
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 6 Page(s): 420 - 420
  09/01/1995 Authors: GUASCH A; CUA M; YOU W; MITCH WE
• DETERMINANTS OF HYPOFILTRATION IN HUMAN RENAL-ALLOGRAFTS
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 6 Page(s): 1088 - 1088
  09/01/1995 Authors: GUASCH A; CUA M; SOMEREN A; NEYLAN JF
• SHORT-TERM COMPARISON OF ACE-INHIBITION VS CALCIUM-CHANNEL BLOCKADE IN AFRICAN-AMERICANS WITH TYPE-II DIABETES-MELLITUS AND NEPHROPATHY
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 6 Page(s): 447 - 447
  09/01/1995 Authors: CAMPBELL O; CUA M; PARHAM M; YOU W; MACON E; GUASCH A
• PATHOPHYSIOLOGY OF GLOMERULAR INJURY IN SICKLE-CELL GLOMERULOPATHY
  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 5 Page(s): 351 - 351
  09/01/1994 Authors: GUASCH A; WADE C; MITCH WE
• Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy.
  J Am Soc Nephrol Volume: 4 Page(s): 1571 - 1581
  02/01/1994 Authors: Guasch A; Myers BD
• Mechanisms of proteinuria in nephrotic humans.
  Pediatr Nephrol Volume: 8 Page(s): 107 - 112
  02/01/1994 Authors: Myers BD; Guasch A
• Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
  J Clin Invest Volume: 92 Page(s): 2274 - 2282
  11/01/1993 Authors: Guasch A; Deen WM; Myers BD
• Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans.
  Am J Kidney Dis Volume: 21 Page(s): 251 - 259
  03/01/1993 Authors: Suranyi MG; Guasch A; Hall BM; Myers BD
• Selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
  Am J Nephrol Volume: 13 Page(s): 311 - 317
  01/01/1993 Authors: Myers BD; Guasch A
• EXTENT AND COURSE OF GLOMERULAR INJURY IN HUMAN MEMBRANOUS GLOMERULOPATHY
  AMERICAN JOURNAL OF PHYSIOLOGY Volume: 263 Page(s): F1034 - F1043
  12/01/1992 Authors: GUASCH A; SIBLEY RK; HUIE P; MYERS BD
• Extent and course of glomerular injury in human membranous glomerulopathy.
  Am J Physiol Volume: 263 Page(s): F1034 - F1043
  12/01/1992 Authors: Guasch A; Sibley RK; Huie P; Myers BD
• Short-term responsiveness of membranous glomerulopathy to cyclosporine.
  Am J Kidney Dis Volume: 20 Page(s): 472 - 481
  11/01/1992 Authors: Guasch A; Suranyi M; Newton L; Hall BM; Myers BD
• GLOMERULAR DYSFUNCTION IN NEPHROTIC HUMANS WITH MINIMAL CHANGES OR FOCAL GLOMERULOSCLEROSIS
  AMERICAN JOURNAL OF PHYSIOLOGY Volume: 260 Page(s): F728 - F737
  05/01/1991 Authors: GUASCH A; HASHIMOTO H; SIBLEY RK; DEEN WM; MYERS BD
• Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis.
  Am J Physiol Volume: 260 Page(s): F728 - F737
  05/01/1991 Authors: Guasch A; Hashimoto H; Sibley RK; Deen WM; Myers BD
• THE NEPHROTIC SYNDROME - ROLE OF CYTOKINES
  KIDNEY INTERNATIONAL Volume: 38 Page(s): 557 - 557
  09/01/1990 Authors: SURANYI MG; QUIZA C; GUASCH A; NEWTON L; MYERS BD; HALL BM